NURS FPX 4900 Assessment 2 Assessing the Problem Quality Safety and Cost Considerations
Phillip April 19, 2024 No Comments

Assessing the Problem Quality Safety and Cost Considerations

NURS FPX 4900 Assessment 2 Assessing the Problem Quality Safety and Cost Considerations


Capella university

NURS-FPX 4900 Capstone project for Nursing

Prof. Name


Assessing the Problem: Patient, Family, or Population Health Problem Solution

The purpose of this assessment is to delve into the ramifications of poorly managed Type 2 diabetes and obesity concerning the standard of care, patient well-being, and financial burden on the healthcare system and individuals. The analysis is rooted in two practicum hours spent with John, the patient, and consultations with subject matter experts, encompassing diabetes nurse specialists, nutritionists, and other healthcare professionals. Furthermore, the assessment scrutinizes the impact of nursing practice standards, organizational policies, and governmental regulations on the issue while advocating evidence-based strategies to address these concerns.

The report underscores the pivotal role of collaboration, communication, and leadership in Type 2 diabetes and obesity management, underlining the significance of a multidisciplinary approach to bolster patient outcomes. Finally, the conclusion underscores the necessity of implementing evidence-based strategies to augment patient care, safety, and outcomes while mitigating healthcare costs.

Practicum Hours Experience

During the practicum hours, interactions occurred with John, his family, a diabetes nurse specialist, and a nutritionist. These encounters shed light on the challenges John and his family encounter in managing his diabetes, underscored the importance of patient education and self-care, and underscored the necessity of a multidisciplinary approach to ameliorate his condition. A review of evidence-based practice documents and websites further augmented understanding regarding best practices for diabetes management and the significance of patient-centered care.

Impact on Quality of Care, Patient Safety, and Costs

The management of Type 2 diabetes and obesity holds significant sway over the quality of care and patient safety. Poorly managed diabetes heightens the risk of complications such as kidney disease, nerve damage, and cardiovascular issues (Li et al., 2020). Obesity exacerbates these concerns, further amplifying the risk of comorbidities (Zhou et al., 2020). In John’s case, inadequate management of his diabetes and obesity not only compromises his overall quality of care but also imperils his safety. For instance, uncontrolled blood sugar levels can precipitate hypoglycemia, potentially resulting in sudden loss of consciousness and posing a substantial risk to patient safety.

The economic burden of Type 2 diabetes and obesity on both the healthcare system and individuals is staggering. Direct medical costs of diabetes are estimated at approximately $327 billion annually in the United States (Li et al., 2020). These expenses encompass costs related to medications, medical services, and productivity losses stemming from diabetes-related morbidity and mortality. Moreover, obesity-related medical costs hover around $147 billion per year (Burd et al., 2020). In John’s scenario, the financial strain associated with managing his diabetes and obesity could engender difficulties in affording medications and adhering to a healthy diet.

This dearth of resources can culminate in poorer health outcomes and heightened healthcare utilization, thereby exacerbating strain on the healthcare system. Addressing these challenges mandates effective management strategies, patient education, and multidisciplinary care to enhance health outcomes and curtail healthcare costs.

Impact of State Board Nursing Practice Standards and Policies on Type 2 Diabetes Management

State Board Nursing Practice Standards

State board nursing practice standards wield significant influence in Type 2 diabetes and obesity management, furnishing nurses with guidance to deliver evidence-based care to patients. These standards ensure that nurses adeptly assess, plan, and execute diabetes management, thereby fostering patient safety and optimal health outcomes (Seaton et al., 2020). For instance, these standards underscore the import of nursing assessment, care planning, personalized patient education, and routine monitoring of diabetes patients. By adhering to these practice standards, nurses can efficaciously manage diabetes, thereby mitigating the risk of complications and associated healthcare costs.

In addition, a comprehensive synthesis of literature buttresses these standards. Research indicates that a multidisciplinary approach to diabetes management engenders improved outcomes for patients (Zhou et al., 2020). Moreover, the American Diabetes Association (ADA) has delineated the Standards of Medical Care in Diabetes, furnishing comprehensive guidelines on diabetes management encompassing diagnosis, treatment, and prevention (Li et al., 2020). These guidelines serve as a cornerstone for healthcare organizations to devise policies and protocols, thereby ensuring the dispensation of high-quality, evidence-based care to diabetes patients.

Organizational and Governmental Policies

Policies at both organizational and governmental echelons wield considerable sway in Type 2 diabetes and obesity management. Examples include the Affordable Care Act (ACA) and the 21st Century Cures Act, which bear implications for diabetes management. The ACA earmarks funding for programs geared toward preventing and managing chronic conditions such as diabetes, while the 21st Century Cures Act encompasses provisions pertinent to the utilization of digital health technologies in healthcare (Zhou et al., 2020).

One organizational policy germane to diabetes management is the adoption of electronic health records (EHRs). EHRs facilitate more streamlined and coordinated care, empowering healthcare professionals to readily access and disseminate patient information. Additionally, EHRs can expedite population health management, enabling organizations to identify at-risk diabetes patients and institute interventions to prevent or manage the condition (Hohman et al., 2023).

Furthermore, the American Diabetes Association (ADA) has promulgated the Standards of Medical Care in Diabetes, an exhaustive compendium of guidelines spanning various facets of diabetes management such as diagnosis, treatment, and prevention (Li et al., 2020). These guidelines furnish healthcare organizations with a foundation to devise policies and protocols aimed at furnishing high-quality, evidence-based care to diabetes patients. By integrating contemporaneous evidence-based guidelines from the ADA and other sources, healthcare organizations can ensure the provision of the most efficacious interventions for managing diabetes and obesity.

Policy Effects on Nursing Scope of Practice and Intervention

The policies and standards attendant to Type 2 diabetes management exert a pivotal influence on delineating the scope of nursing practice, shaping how nurses assess, plan, and furnish care to diabetes patients. For instance, nursing practice standards stipulated by state boards and guidelines promulgated by the ADA mandate that nurses possess a robust grasp of evidence-based practices, wield critical thinking skills while assessing and managing diabetes patients, and partake in continuous professional development to remain apprised of the latest research and best practices (Li et al., 2020; Seaton et al., 2020). These standards and policies will steer nursing interventions to ensure the delivery of high-quality, evidence-based care to John.

Interventions may encompass tailoring diabetes management education to John’s idiosyncratic needs, collaborating with a healthcare professional team to devise a patient-centered care plan, and continuously monitoring John’s progress and adjusting the care plan as warranted. By aligning with these standards and policies, nurses can efficaciously contend with the intricacies of Type 2 diabetes management, thereby bolstering the quality of care, patient safety, and curtailing costs for the system and the individual.

Evidence-Based Strategies to Improve Quality of Care, Patient Safety, and Costs

To ameliorate the deleterious impact of Type 2 diabetes and obesity on the quality of care, patient safety, and costs for both the healthcare system and individuals, the adoption of evidence-based strategies is imperative. These strategies must be comprehensive and patient-centered to engender superior health outcomes and mitigate the financial burden associated with diabetes management. The ensuing strategies endeavor to fortify the quality of care, patient safety, and reduce costs for both the healthcare system and individuals:

Patient Education and Self-Care:

Furnish John and his family with a tailored education program spotlighting diabetes management, diet, exercise, and medication adherence. Emphasize the import of self-monitoring blood glucose levels and adhering to a healthy lifestyle. Recent research evinces that patient education and self-care correlate with enhanced diabetes control and diminished complications (Romero-Castillo et al., 2022). Additionally, integrate continuous glucose monitoring (CGM) technology for more precise and real-time blood glucose monitoring.

Multidisciplinary Approach:

Forge a collaborative care team encompassing a diabetes nurse specialist, nutritionist, and other healthcare professionals. This coalition will collaborate to craft a comprehensive, patient-centric care plan tailored to John’s specific exigencies. Studies evince that a multidisciplinary approach augments outcomes for diabetes patients. Furthermore, integrate telehealth and digital applications such as wearables to monitor his lifestyle changes and glucose levels. This fosters more streamlined and convenient progress tracking and access to live coaching upon entering glucose readings (Cannata et al., 2020).

Evidence-Based Practices:

Leverage contemporary evidence-based recommendations from the American Diabetes Association and the American Association of Diabetes Educators to inform the care plan. This practice ensures that John receives the most pertinent interventions for managing his diabetes and obesity (Li et al., 2020).

Continuous Monitoring and Evaluation:

Routinely assess John’s progress, comprising blood glucose levels, weight, and adherence to the care plan. Modify the care plan as necessary based on assessment findings, thereby guaranteeing that John receives optimal, personalized care. Continuous monitoring and evaluation have demonstrated efficacy in enhancing patient outcomes and mitigating the risk of complications (Sora et al., 2019).

By implementing these strategies, the objective is to refine John’s diabetes management, attenuate complications, and mitigate associated healthcare costs. Complying with requirements, document the practicum hours expended with John and his family in the CORE ELMS Volunteer Experience Form. This documentation will serve as a testament to the time invested in implementing these strategies and gauging their efficacy.


In summation, addressing the quandaries posed by Type 2 diabetes and obesity necessitates a comprehensive, evidence-based approach to amplify the quality of care, patient safety, and cost-effectiveness for both the healthcare system and the individual. By adopting strategies such as patient education and self-care, a multidisciplinary approach, adherence to evidence-based practices, and continuous monitoring and evaluation, continuous glucose monitoring (CGM), telehealth, and digital applications. it is feasible to attain superior health outcomes for patients akin to John. Moreover, comprehending the role of nursing practice standards and organizational policies in shaping the healthcare milieu is imperative to ensure the implementation of appropriate interventions. Ultimately, collaboration, communication, and leadership are pivotal in fostering a patient-centric care milieu that underpins optimal well-being.


Burd, C., Gruss, S., Albright, A., Zina, A., Schumacher, P., & Alley, D. (2020). Translating knowledge into action to prevent type 2 diabetes: Medicare expansion of the national diabetes prevention program lifestyle intervention. The Milbank Quarterly, 98(1), 172–196.

Cannata, F., Vadalà, G., Russo, F., Papalia, R., Napoli, N., & Pozzilli, P. (2020). Beneficial effects of physical activity in diabetic patients. Journal of Functional Morphology and Kinesiology, 5(3), 70.

Hohman, K. H., Martinez, A. K., Klompas, M., Kraus, E. M., Li, W., Carton, T. W., Cocoros, N. M., Jackson, S. L., Karras, B. T., Wiltz, J. L., & Wall, H. K. (2023). Leveraging Electronic Health Record Data for Timely Chronic Disease Surveillance: The Multi-State EHR-Based Network for Disease Surveillance. Journal of Public Health Management and Practice, 29(2), 162.

NURS FPX 4900 Assessment 2 Assessing the Problem Quality Safety and Cost Considerations

Li, Y., Teng, D., Shi, X., Qin, G., Qin, Y., Quan, H., Shi, B., Sun, H., Ba, J., Chen, B., Du, J., He, L., Lai, X., Li, Y., Chi, H., Liao, E., Liu, C., Liu, L., Tang, X., & Tong, N. (2020). Prevalence of diabetes recorded in mainland china using 2018 diagnostic criteria from the american diabetes association: National cross sectional study. BMJ, 369, m997.

Romero-Castillo, R., Pabón-Carrasco, M., Jiménez-Picón, N., & Ponce-Blandón, J. A. (2022). Effects of nursing diabetes self-management education on glycemic control and self-care in type 1 diabetes: Study protocol. International Journal of Environmental Research and Public Health, 19(9), 5079.

Seaton, P. C. J., Cant, R. P., & Trip, H. T. (2020). Quality indicators for a community‐based wound care centre: An integrative review. International Wound Journal, 17(3), 587–600.

Sora, N. D., Shashpal, F., Bond, E. A., & Jenkins, A. J. (2019). Insulin pumps: Review of technological advancement in diabetes management. The American Journal of the Medical Sciences, 358(5), 326–331.

Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2020). Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 ( COVID ‐19). Diabetes/Metabolism Research and Reviews, 37(2).